Review




Structured Review

Ambeed Inc lpv lopinavir
Lpv Lopinavir, supplied by Ambeed Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lpv lopinavir/product/Ambeed Inc
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
lpv lopinavir - by Bioz Stars, 2025-01
86/100 stars

Images



Similar Products

94
MedChemExpress lpv
Replication stress response defects and genomic instability in prelamin A‐expressing cells. a) SA‐β‐gal staining of IMR90‐hTERT fibroblasts treated with DMSO or <t>LPV</t> (20 µ m ) for 2 weeks. Scale bars: 100 µm. The percentage of SA‐β‐gal‐positive cells was calculated. n = 3. b) The level of γH2AX in prelamin A‐expressing ( ZMPSTE24 ‐knockdown or LPV‐treated) cells was measured by western blotting. n = 3. c) Immunofluorescence staining of 53BP1 in control and prelamin A‐expressing (LPV‐treated) cells with or <t>without</t> <t>APH</t> (0.4 µ m , 24 h) treatment. Scale bars: 10 µm. The number of 53BP1 bodies per nucleus was calculated. d) Immunofluorescence staining of lamin A/C in shCTRL and shZMPSTE24 cells. Scale bars: 10 µm. The percentage of micronuclei was calculated. n = 3. e) The proliferation of shCTRL and shZMPSTE24 cells was measured (left). The viability of shCTRL and shZMPSTE24 cells treated with the indicated concentrations of HU was measured (right). n = 3. f) Chromosomal aberrations, including breaks, gaps, rings, and dicentric chromosomes were analyzed for each metaphase in control and prelamin A‐expressing (LPV‐treated) cells with or without APH (0.3 µ m , 16 h) treatment. g) Chromosomal aberrations were analyzed for each metaphase in control and prelamin A‐expressing (LPV‐treated) cells with or without HU (4 mм, 4 h) and mirin (50 µ m , 4 h) treatment. Quantitative analysis results are shown as the mean ± SD. P values were determined by unpaired Student's t‐ test (a, b, d, and e) and the Mann‒Whitney test (c, f, and g). * p < 0.05; ** p < 0.01; *** p < 0.001.
Lpv, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lpv/product/MedChemExpress
Average 94 stars, based on 1 article reviews
Price from $9.99 to $1999.99
lpv - by Bioz Stars, 2025-01
94/100 stars
  Buy from Supplier

86
Ambeed Inc lpv lopinavir
Replication stress response defects and genomic instability in prelamin A‐expressing cells. a) SA‐β‐gal staining of IMR90‐hTERT fibroblasts treated with DMSO or <t>LPV</t> (20 µ m ) for 2 weeks. Scale bars: 100 µm. The percentage of SA‐β‐gal‐positive cells was calculated. n = 3. b) The level of γH2AX in prelamin A‐expressing ( ZMPSTE24 ‐knockdown or LPV‐treated) cells was measured by western blotting. n = 3. c) Immunofluorescence staining of 53BP1 in control and prelamin A‐expressing (LPV‐treated) cells with or <t>without</t> <t>APH</t> (0.4 µ m , 24 h) treatment. Scale bars: 10 µm. The number of 53BP1 bodies per nucleus was calculated. d) Immunofluorescence staining of lamin A/C in shCTRL and shZMPSTE24 cells. Scale bars: 10 µm. The percentage of micronuclei was calculated. n = 3. e) The proliferation of shCTRL and shZMPSTE24 cells was measured (left). The viability of shCTRL and shZMPSTE24 cells treated with the indicated concentrations of HU was measured (right). n = 3. f) Chromosomal aberrations, including breaks, gaps, rings, and dicentric chromosomes were analyzed for each metaphase in control and prelamin A‐expressing (LPV‐treated) cells with or without APH (0.3 µ m , 16 h) treatment. g) Chromosomal aberrations were analyzed for each metaphase in control and prelamin A‐expressing (LPV‐treated) cells with or without HU (4 mм, 4 h) and mirin (50 µ m , 4 h) treatment. Quantitative analysis results are shown as the mean ± SD. P values were determined by unpaired Student's t‐ test (a, b, d, and e) and the Mann‒Whitney test (c, f, and g). * p < 0.05; ** p < 0.01; *** p < 0.001.
Lpv Lopinavir, supplied by Ambeed Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lpv lopinavir/product/Ambeed Inc
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
lpv lopinavir - by Bioz Stars, 2025-01
86/100 stars
  Buy from Supplier

86
Millipore standard is lopinavir lpv
Replication stress response defects and genomic instability in prelamin A‐expressing cells. a) SA‐β‐gal staining of IMR90‐hTERT fibroblasts treated with DMSO or <t>LPV</t> (20 µ m ) for 2 weeks. Scale bars: 100 µm. The percentage of SA‐β‐gal‐positive cells was calculated. n = 3. b) The level of γH2AX in prelamin A‐expressing ( ZMPSTE24 ‐knockdown or LPV‐treated) cells was measured by western blotting. n = 3. c) Immunofluorescence staining of 53BP1 in control and prelamin A‐expressing (LPV‐treated) cells with or <t>without</t> <t>APH</t> (0.4 µ m , 24 h) treatment. Scale bars: 10 µm. The number of 53BP1 bodies per nucleus was calculated. d) Immunofluorescence staining of lamin A/C in shCTRL and shZMPSTE24 cells. Scale bars: 10 µm. The percentage of micronuclei was calculated. n = 3. e) The proliferation of shCTRL and shZMPSTE24 cells was measured (left). The viability of shCTRL and shZMPSTE24 cells treated with the indicated concentrations of HU was measured (right). n = 3. f) Chromosomal aberrations, including breaks, gaps, rings, and dicentric chromosomes were analyzed for each metaphase in control and prelamin A‐expressing (LPV‐treated) cells with or without APH (0.3 µ m , 16 h) treatment. g) Chromosomal aberrations were analyzed for each metaphase in control and prelamin A‐expressing (LPV‐treated) cells with or without HU (4 mм, 4 h) and mirin (50 µ m , 4 h) treatment. Quantitative analysis results are shown as the mean ± SD. P values were determined by unpaired Student's t‐ test (a, b, d, and e) and the Mann‒Whitney test (c, f, and g). * p < 0.05; ** p < 0.01; *** p < 0.001.
Standard Is Lopinavir Lpv, supplied by Millipore, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/standard is lopinavir lpv/product/Millipore
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
standard is lopinavir lpv - by Bioz Stars, 2025-01
86/100 stars
  Buy from Supplier

86
Glaxo Smith glaxosmithkline vx 478 kaletra lopinavir lpv abt
Replication stress response defects and genomic instability in prelamin A‐expressing cells. a) SA‐β‐gal staining of IMR90‐hTERT fibroblasts treated with DMSO or <t>LPV</t> (20 µ m ) for 2 weeks. Scale bars: 100 µm. The percentage of SA‐β‐gal‐positive cells was calculated. n = 3. b) The level of γH2AX in prelamin A‐expressing ( ZMPSTE24 ‐knockdown or LPV‐treated) cells was measured by western blotting. n = 3. c) Immunofluorescence staining of 53BP1 in control and prelamin A‐expressing (LPV‐treated) cells with or <t>without</t> <t>APH</t> (0.4 µ m , 24 h) treatment. Scale bars: 10 µm. The number of 53BP1 bodies per nucleus was calculated. d) Immunofluorescence staining of lamin A/C in shCTRL and shZMPSTE24 cells. Scale bars: 10 µm. The percentage of micronuclei was calculated. n = 3. e) The proliferation of shCTRL and shZMPSTE24 cells was measured (left). The viability of shCTRL and shZMPSTE24 cells treated with the indicated concentrations of HU was measured (right). n = 3. f) Chromosomal aberrations, including breaks, gaps, rings, and dicentric chromosomes were analyzed for each metaphase in control and prelamin A‐expressing (LPV‐treated) cells with or without APH (0.3 µ m , 16 h) treatment. g) Chromosomal aberrations were analyzed for each metaphase in control and prelamin A‐expressing (LPV‐treated) cells with or without HU (4 mм, 4 h) and mirin (50 µ m , 4 h) treatment. Quantitative analysis results are shown as the mean ± SD. P values were determined by unpaired Student's t‐ test (a, b, d, and e) and the Mann‒Whitney test (c, f, and g). * p < 0.05; ** p < 0.01; *** p < 0.001.
Glaxosmithkline Vx 478 Kaletra Lopinavir Lpv Abt, supplied by Glaxo Smith, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/glaxosmithkline vx 478 kaletra lopinavir lpv abt/product/Glaxo Smith
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
glaxosmithkline vx 478 kaletra lopinavir lpv abt - by Bioz Stars, 2025-01
86/100 stars
  Buy from Supplier

86
Thermo Fisher nih hiv reagent program hrp 10199 raltegravir ral nih hiv reagent program hrp 11680 lopinavir lpv
Replication stress response defects and genomic instability in prelamin A‐expressing cells. a) SA‐β‐gal staining of IMR90‐hTERT fibroblasts treated with DMSO or <t>LPV</t> (20 µ m ) for 2 weeks. Scale bars: 100 µm. The percentage of SA‐β‐gal‐positive cells was calculated. n = 3. b) The level of γH2AX in prelamin A‐expressing ( ZMPSTE24 ‐knockdown or LPV‐treated) cells was measured by western blotting. n = 3. c) Immunofluorescence staining of 53BP1 in control and prelamin A‐expressing (LPV‐treated) cells with or <t>without</t> <t>APH</t> (0.4 µ m , 24 h) treatment. Scale bars: 10 µm. The number of 53BP1 bodies per nucleus was calculated. d) Immunofluorescence staining of lamin A/C in shCTRL and shZMPSTE24 cells. Scale bars: 10 µm. The percentage of micronuclei was calculated. n = 3. e) The proliferation of shCTRL and shZMPSTE24 cells was measured (left). The viability of shCTRL and shZMPSTE24 cells treated with the indicated concentrations of HU was measured (right). n = 3. f) Chromosomal aberrations, including breaks, gaps, rings, and dicentric chromosomes were analyzed for each metaphase in control and prelamin A‐expressing (LPV‐treated) cells with or without APH (0.3 µ m , 16 h) treatment. g) Chromosomal aberrations were analyzed for each metaphase in control and prelamin A‐expressing (LPV‐treated) cells with or without HU (4 mм, 4 h) and mirin (50 µ m , 4 h) treatment. Quantitative analysis results are shown as the mean ± SD. P values were determined by unpaired Student's t‐ test (a, b, d, and e) and the Mann‒Whitney test (c, f, and g). * p < 0.05; ** p < 0.01; *** p < 0.001.
Nih Hiv Reagent Program Hrp 10199 Raltegravir Ral Nih Hiv Reagent Program Hrp 11680 Lopinavir Lpv, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nih hiv reagent program hrp 10199 raltegravir ral nih hiv reagent program hrp 11680 lopinavir lpv/product/Thermo Fisher
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
nih hiv reagent program hrp 10199 raltegravir ral nih hiv reagent program hrp 11680 lopinavir lpv - by Bioz Stars, 2025-01
86/100 stars
  Buy from Supplier

86
Biomol GmbH lopinavir lpv
Replication stress response defects and genomic instability in prelamin A‐expressing cells. a) SA‐β‐gal staining of IMR90‐hTERT fibroblasts treated with DMSO or <t>LPV</t> (20 µ m ) for 2 weeks. Scale bars: 100 µm. The percentage of SA‐β‐gal‐positive cells was calculated. n = 3. b) The level of γH2AX in prelamin A‐expressing ( ZMPSTE24 ‐knockdown or LPV‐treated) cells was measured by western blotting. n = 3. c) Immunofluorescence staining of 53BP1 in control and prelamin A‐expressing (LPV‐treated) cells with or <t>without</t> <t>APH</t> (0.4 µ m , 24 h) treatment. Scale bars: 10 µm. The number of 53BP1 bodies per nucleus was calculated. d) Immunofluorescence staining of lamin A/C in shCTRL and shZMPSTE24 cells. Scale bars: 10 µm. The percentage of micronuclei was calculated. n = 3. e) The proliferation of shCTRL and shZMPSTE24 cells was measured (left). The viability of shCTRL and shZMPSTE24 cells treated with the indicated concentrations of HU was measured (right). n = 3. f) Chromosomal aberrations, including breaks, gaps, rings, and dicentric chromosomes were analyzed for each metaphase in control and prelamin A‐expressing (LPV‐treated) cells with or without APH (0.3 µ m , 16 h) treatment. g) Chromosomal aberrations were analyzed for each metaphase in control and prelamin A‐expressing (LPV‐treated) cells with or without HU (4 mм, 4 h) and mirin (50 µ m , 4 h) treatment. Quantitative analysis results are shown as the mean ± SD. P values were determined by unpaired Student's t‐ test (a, b, d, and e) and the Mann‒Whitney test (c, f, and g). * p < 0.05; ** p < 0.01; *** p < 0.001.
Lopinavir Lpv, supplied by Biomol GmbH, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lopinavir lpv/product/Biomol GmbH
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
lopinavir lpv - by Bioz Stars, 2025-01
86/100 stars
  Buy from Supplier

86
Millipore lopinavir lpv
Replication stress response defects and genomic instability in prelamin A‐expressing cells. a) SA‐β‐gal staining of IMR90‐hTERT fibroblasts treated with DMSO or <t>LPV</t> (20 µ m ) for 2 weeks. Scale bars: 100 µm. The percentage of SA‐β‐gal‐positive cells was calculated. n = 3. b) The level of γH2AX in prelamin A‐expressing ( ZMPSTE24 ‐knockdown or LPV‐treated) cells was measured by western blotting. n = 3. c) Immunofluorescence staining of 53BP1 in control and prelamin A‐expressing (LPV‐treated) cells with or <t>without</t> <t>APH</t> (0.4 µ m , 24 h) treatment. Scale bars: 10 µm. The number of 53BP1 bodies per nucleus was calculated. d) Immunofluorescence staining of lamin A/C in shCTRL and shZMPSTE24 cells. Scale bars: 10 µm. The percentage of micronuclei was calculated. n = 3. e) The proliferation of shCTRL and shZMPSTE24 cells was measured (left). The viability of shCTRL and shZMPSTE24 cells treated with the indicated concentrations of HU was measured (right). n = 3. f) Chromosomal aberrations, including breaks, gaps, rings, and dicentric chromosomes were analyzed for each metaphase in control and prelamin A‐expressing (LPV‐treated) cells with or without APH (0.3 µ m , 16 h) treatment. g) Chromosomal aberrations were analyzed for each metaphase in control and prelamin A‐expressing (LPV‐treated) cells with or without HU (4 mм, 4 h) and mirin (50 µ m , 4 h) treatment. Quantitative analysis results are shown as the mean ± SD. P values were determined by unpaired Student's t‐ test (a, b, d, and e) and the Mann‒Whitney test (c, f, and g). * p < 0.05; ** p < 0.01; *** p < 0.001.
Lopinavir Lpv, supplied by Millipore, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lopinavir lpv/product/Millipore
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
lopinavir lpv - by Bioz Stars, 2025-01
86/100 stars
  Buy from Supplier

86
Gilead Sciences hcq plus lopinavir ritonavir lpv rtv 18
Replication stress response defects and genomic instability in prelamin A‐expressing cells. a) SA‐β‐gal staining of IMR90‐hTERT fibroblasts treated with DMSO or <t>LPV</t> (20 µ m ) for 2 weeks. Scale bars: 100 µm. The percentage of SA‐β‐gal‐positive cells was calculated. n = 3. b) The level of γH2AX in prelamin A‐expressing ( ZMPSTE24 ‐knockdown or LPV‐treated) cells was measured by western blotting. n = 3. c) Immunofluorescence staining of 53BP1 in control and prelamin A‐expressing (LPV‐treated) cells with or <t>without</t> <t>APH</t> (0.4 µ m , 24 h) treatment. Scale bars: 10 µm. The number of 53BP1 bodies per nucleus was calculated. d) Immunofluorescence staining of lamin A/C in shCTRL and shZMPSTE24 cells. Scale bars: 10 µm. The percentage of micronuclei was calculated. n = 3. e) The proliferation of shCTRL and shZMPSTE24 cells was measured (left). The viability of shCTRL and shZMPSTE24 cells treated with the indicated concentrations of HU was measured (right). n = 3. f) Chromosomal aberrations, including breaks, gaps, rings, and dicentric chromosomes were analyzed for each metaphase in control and prelamin A‐expressing (LPV‐treated) cells with or without APH (0.3 µ m , 16 h) treatment. g) Chromosomal aberrations were analyzed for each metaphase in control and prelamin A‐expressing (LPV‐treated) cells with or without HU (4 mм, 4 h) and mirin (50 µ m , 4 h) treatment. Quantitative analysis results are shown as the mean ± SD. P values were determined by unpaired Student's t‐ test (a, b, d, and e) and the Mann‒Whitney test (c, f, and g). * p < 0.05; ** p < 0.01; *** p < 0.001.
Hcq Plus Lopinavir Ritonavir Lpv Rtv 18, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hcq plus lopinavir ritonavir lpv rtv 18/product/Gilead Sciences
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
hcq plus lopinavir ritonavir lpv rtv 18 - by Bioz Stars, 2025-01
86/100 stars
  Buy from Supplier

86
Glaxo Smith vx 478 glaxosmithkline kaletra lopinavir lpv abt
Replication stress response defects and genomic instability in prelamin A‐expressing cells. a) SA‐β‐gal staining of IMR90‐hTERT fibroblasts treated with DMSO or <t>LPV</t> (20 µ m ) for 2 weeks. Scale bars: 100 µm. The percentage of SA‐β‐gal‐positive cells was calculated. n = 3. b) The level of γH2AX in prelamin A‐expressing ( ZMPSTE24 ‐knockdown or LPV‐treated) cells was measured by western blotting. n = 3. c) Immunofluorescence staining of 53BP1 in control and prelamin A‐expressing (LPV‐treated) cells with or <t>without</t> <t>APH</t> (0.4 µ m , 24 h) treatment. Scale bars: 10 µm. The number of 53BP1 bodies per nucleus was calculated. d) Immunofluorescence staining of lamin A/C in shCTRL and shZMPSTE24 cells. Scale bars: 10 µm. The percentage of micronuclei was calculated. n = 3. e) The proliferation of shCTRL and shZMPSTE24 cells was measured (left). The viability of shCTRL and shZMPSTE24 cells treated with the indicated concentrations of HU was measured (right). n = 3. f) Chromosomal aberrations, including breaks, gaps, rings, and dicentric chromosomes were analyzed for each metaphase in control and prelamin A‐expressing (LPV‐treated) cells with or without APH (0.3 µ m , 16 h) treatment. g) Chromosomal aberrations were analyzed for each metaphase in control and prelamin A‐expressing (LPV‐treated) cells with or without HU (4 mм, 4 h) and mirin (50 µ m , 4 h) treatment. Quantitative analysis results are shown as the mean ± SD. P values were determined by unpaired Student's t‐ test (a, b, d, and e) and the Mann‒Whitney test (c, f, and g). * p < 0.05; ** p < 0.01; *** p < 0.001.
Vx 478 Glaxosmithkline Kaletra Lopinavir Lpv Abt, supplied by Glaxo Smith, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vx 478 glaxosmithkline kaletra lopinavir lpv abt/product/Glaxo Smith
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
vx 478 glaxosmithkline kaletra lopinavir lpv abt - by Bioz Stars, 2025-01
86/100 stars
  Buy from Supplier

Image Search Results


Replication stress response defects and genomic instability in prelamin A‐expressing cells. a) SA‐β‐gal staining of IMR90‐hTERT fibroblasts treated with DMSO or LPV (20 µ m ) for 2 weeks. Scale bars: 100 µm. The percentage of SA‐β‐gal‐positive cells was calculated. n = 3. b) The level of γH2AX in prelamin A‐expressing ( ZMPSTE24 ‐knockdown or LPV‐treated) cells was measured by western blotting. n = 3. c) Immunofluorescence staining of 53BP1 in control and prelamin A‐expressing (LPV‐treated) cells with or without APH (0.4 µ m , 24 h) treatment. Scale bars: 10 µm. The number of 53BP1 bodies per nucleus was calculated. d) Immunofluorescence staining of lamin A/C in shCTRL and shZMPSTE24 cells. Scale bars: 10 µm. The percentage of micronuclei was calculated. n = 3. e) The proliferation of shCTRL and shZMPSTE24 cells was measured (left). The viability of shCTRL and shZMPSTE24 cells treated with the indicated concentrations of HU was measured (right). n = 3. f) Chromosomal aberrations, including breaks, gaps, rings, and dicentric chromosomes were analyzed for each metaphase in control and prelamin A‐expressing (LPV‐treated) cells with or without APH (0.3 µ m , 16 h) treatment. g) Chromosomal aberrations were analyzed for each metaphase in control and prelamin A‐expressing (LPV‐treated) cells with or without HU (4 mм, 4 h) and mirin (50 µ m , 4 h) treatment. Quantitative analysis results are shown as the mean ± SD. P values were determined by unpaired Student's t‐ test (a, b, d, and e) and the Mann‒Whitney test (c, f, and g). * p < 0.05; ** p < 0.01; *** p < 0.001.

Journal: Advanced Science

Article Title: The Compromised Fanconi Anemia Pathway in Prelamin A‐Expressing Cells Contributes to Replication Stress‐Induced Genomic Instability

doi: 10.1002/advs.202307751

Figure Lengend Snippet: Replication stress response defects and genomic instability in prelamin A‐expressing cells. a) SA‐β‐gal staining of IMR90‐hTERT fibroblasts treated with DMSO or LPV (20 µ m ) for 2 weeks. Scale bars: 100 µm. The percentage of SA‐β‐gal‐positive cells was calculated. n = 3. b) The level of γH2AX in prelamin A‐expressing ( ZMPSTE24 ‐knockdown or LPV‐treated) cells was measured by western blotting. n = 3. c) Immunofluorescence staining of 53BP1 in control and prelamin A‐expressing (LPV‐treated) cells with or without APH (0.4 µ m , 24 h) treatment. Scale bars: 10 µm. The number of 53BP1 bodies per nucleus was calculated. d) Immunofluorescence staining of lamin A/C in shCTRL and shZMPSTE24 cells. Scale bars: 10 µm. The percentage of micronuclei was calculated. n = 3. e) The proliferation of shCTRL and shZMPSTE24 cells was measured (left). The viability of shCTRL and shZMPSTE24 cells treated with the indicated concentrations of HU was measured (right). n = 3. f) Chromosomal aberrations, including breaks, gaps, rings, and dicentric chromosomes were analyzed for each metaphase in control and prelamin A‐expressing (LPV‐treated) cells with or without APH (0.3 µ m , 16 h) treatment. g) Chromosomal aberrations were analyzed for each metaphase in control and prelamin A‐expressing (LPV‐treated) cells with or without HU (4 mм, 4 h) and mirin (50 µ m , 4 h) treatment. Quantitative analysis results are shown as the mean ± SD. P values were determined by unpaired Student's t‐ test (a, b, d, and e) and the Mann‒Whitney test (c, f, and g). * p < 0.05; ** p < 0.01; *** p < 0.001.

Article Snippet: LPV (MCE, HY‐14588), FTI‐277 (MCE, HY‐15872A), HU (Sigma–Aldrich, H8627), APH (Glpbio, GC10867), colcemid (Glpbio, GC40664), Nutlin‐3A (MCE, HY‐10029), and mirin (MCE, HY‐117693) were used.

Techniques: Expressing, Staining, Knockdown, Western Blot, Immunofluorescence, Control

Downregulation of the FA/BRCA gene network in prelamin A‐expressing cells. a) The expression of FANCD2 and RAD51 in ZMPSTE24 ‐knockdown cells was measured by western blotting. n = 3. b) mRNA levels of FA/BRCA genes in ZMPSTE24 ‐knockdown cells were measured by qPCR. n = 3. c) Western blotting was used to measure the expression of FANCD2 and RAD51 in cells treated with FTI (3 µ m , 48 h), LPV (20 µ m , 6 days) or LPV + FTI. The farnesylated prelamin A generated by LPV treatment (lane 3) migrated more rapidly than the nonfarnesylated prelamin A generated by FTI treatment (lane 2 and lane 4). n = 3. d) The expression of RAD51 in asynchronous, S‐phase‐synchronized and M‐phase‐synchronized control and ZMPSTE24 ‐knockdown cells was measured by western blotting. Asyn, asynchronous. n = 3. e) The expression of FANCD2 in asynchronous, G1‐phase‐synchronized, S‐phase‐synchronized and M‐phase‐synchronized control and ZMPSTE24 ‐knockdown cells was measured by western blotting. Asyn, asynchronous. n = 3. f) SA‐β‐gal staining of IMR90 fibroblasts at early (P6) and late (P20) passages. Scale bar: 100 µm. g) The protein levels of prelamin A, FANCD2, FANCI and RAD51 in IMR90 fibroblasts at early (P6) and late (P20) passages were detected by western blotting. Quantitative analysis results are shown as the mean ± SD. P values were determined by unpaired Student's t‐ test (a, b, d, and e) and one‐way ANOVA (c). ns, not significant; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.

Journal: Advanced Science

Article Title: The Compromised Fanconi Anemia Pathway in Prelamin A‐Expressing Cells Contributes to Replication Stress‐Induced Genomic Instability

doi: 10.1002/advs.202307751

Figure Lengend Snippet: Downregulation of the FA/BRCA gene network in prelamin A‐expressing cells. a) The expression of FANCD2 and RAD51 in ZMPSTE24 ‐knockdown cells was measured by western blotting. n = 3. b) mRNA levels of FA/BRCA genes in ZMPSTE24 ‐knockdown cells were measured by qPCR. n = 3. c) Western blotting was used to measure the expression of FANCD2 and RAD51 in cells treated with FTI (3 µ m , 48 h), LPV (20 µ m , 6 days) or LPV + FTI. The farnesylated prelamin A generated by LPV treatment (lane 3) migrated more rapidly than the nonfarnesylated prelamin A generated by FTI treatment (lane 2 and lane 4). n = 3. d) The expression of RAD51 in asynchronous, S‐phase‐synchronized and M‐phase‐synchronized control and ZMPSTE24 ‐knockdown cells was measured by western blotting. Asyn, asynchronous. n = 3. e) The expression of FANCD2 in asynchronous, G1‐phase‐synchronized, S‐phase‐synchronized and M‐phase‐synchronized control and ZMPSTE24 ‐knockdown cells was measured by western blotting. Asyn, asynchronous. n = 3. f) SA‐β‐gal staining of IMR90 fibroblasts at early (P6) and late (P20) passages. Scale bar: 100 µm. g) The protein levels of prelamin A, FANCD2, FANCI and RAD51 in IMR90 fibroblasts at early (P6) and late (P20) passages were detected by western blotting. Quantitative analysis results are shown as the mean ± SD. P values were determined by unpaired Student's t‐ test (a, b, d, and e) and one‐way ANOVA (c). ns, not significant; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.

Article Snippet: LPV (MCE, HY‐14588), FTI‐277 (MCE, HY‐15872A), HU (Sigma–Aldrich, H8627), APH (Glpbio, GC10867), colcemid (Glpbio, GC40664), Nutlin‐3A (MCE, HY‐10029), and mirin (MCE, HY‐117693) were used.

Techniques: Expressing, Knockdown, Western Blot, Generated, Control, Staining